ALLR - Company ID 0001860657
Allarity Therapeutics, Inc. trades as ALLR. In its fiscal 2025 annual report the company posted revenue of $320.00K and net income of -$11.23M. This page tracks Allarity Therapeutics, Inc. through 388 SEC filings, with financial statements and metrics updated as new reports are filed.
Research snapshot
Updated
With latest filings
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
Next research step
Dig into the full income statement, balance sheet, and cash flow statement with annual and quarterly views.
| Filing | Type | Filed |
|---|---|---|
| Quarterly report | 10-Q | 2026-05-15 |
| Insider trade | 4 | 2026-05-14 |
| Insider trade | 4 | 2026-05-11 |
| New insider ownership | 3 | 2026-05-11 |
| Major company event | 8-K | 2026-05-08 |
| Insider trade | 4 | 2026-05-07 |
| Major company event | 8-K | 2026-05-06 |
| Annual report to shareholders | ARS | 2026-04-30 |
The largest companies sharing Allarity Therapeutics, Inc.'s SEC industry classification (pharmaceutical preparations).
Allarity Therapeutics, Inc. reported revenue of $320.00K for fiscal year 2025.
In its latest fiscal year Allarity Therapeutics, Inc. reported a net loss of $11.23M.